In the Heidelberg–EPIC study, an association was found between the use of calcium supplements and risk of myocardial infarction, corroborating published data. Given these findings and the absence of clear beneficial effect on fracture risk, the use of these supplements should be discouraged, and individuals advised to obtain calcium from a balanced diet.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Li, K., Kaaks, R., Linseisen, J. & Rohrmann, S. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 98, 920–925 (2012).
Bolland, M. J. et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341, c3691 (2010).
Bolland, M. J., Gray, A., Avenell, A., Gamble, G. D. & Reid, I. R. Calcium supplements with or without vitamin D and risk of cardiovascular events: re-analysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 342, d2040 (2011).
Pentti, K. et al. Use of calcium supplements and the risk of coronary heart disease in 52–62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas 63, 73–78 (2009).
Di Iorio, B., Bellasi, A. & Russo, D. for the INDEPENDENT Study Investigators. Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin. J. Am. Soc. Nephrol. 7, 487–493 (2012).
Russo, D. et al. Progression of coronary artery calcification in predialysis patients. Am. J. Nephrol. 27, 152–158 (2007).
Bolland, M. J. et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336, 262–266 (2008).
Reid, I. R., Bolland, M. J., Sambrook, P. N. & Gray, A. Calcium supplementation: balancing the cardiovascular risks. Maturitas 69, 289–295 (2011).
Reid, I. R., Bolland, M. J., Avenell, A. & Gray, A. Cardiovascular effects of calcium supplementation. Osteoporos. Int. 22, 1649–1658 (2011).
Tang, B. M., Eslick, G. D., Nowson, C., Smith, C. & Bensoussan, A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370, 657–666 (2007).
Acknowledgements
I. R. Reid and M. J. Bolland are supported by the Health Research Council of New Zealand.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
I. R. Reid has acted as a consultant for Sanofi. M. J. Bolland declares no competing interests.
Rights and permissions
About this article
Cite this article
Reid, I., Bolland, M. Calcium supplements and cardiovascular risk. Nat Rev Cardiol 9, 497–498 (2012). https://doi.org/10.1038/nrcardio.2012.101
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2012.101
This article is cited by
-
Calcium supplements—vascular risks versus bone benefits?
Nature Reviews Endocrinology (2013)